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Tomography Images of Bioabsorbable StentsFlare spots (Figures 1A and 1B) are observed in
intravascular optical coherence tomography (IVOCT)
images of bioabsorbable stent struts in patients and
have no analog in metallic stents. Gutiérrez-Chico
et al. (1) proposed that ﬂare spots were located at
hinge points where the highest strain is experienced
during deployment, suggesting that they represent
micro-crazes (ﬁne lines) in the polymer.
Nonetheless, the mechanism for the presence of
ﬂare spots in IVOCT images, and the large variation
in their appearance where no two are alike, is not
known. In this study, micro-CT and IVOCT images of
a bioabsorbable stent deployed in a cylindrical
phantom blood vessel were coregistered and
compared in order to investigate the underlying
mechanism for presence of ﬂare spots in IVOCT
images.
A 3-mm lumen diameter phantom vessel was made
out of polydimethylsiloxane with elastic properties
comparable to that of arteries. Titanium dioxide was
added to polydimethylsiloxane to simulate the light-
scattering properties of the arterial wall. A 3.0  18
Absorb stent (Abbott Vascular, Santa Clara, California)
was deployed within the phantom vessel at 16-atm
pressure with a balloon while submerged in a water
bath at body temperature (37C) to minimize any
structural changes to the polymer. IVOCT images of
the Absorb stent (Figures 1C and 1D) were acquiredusing a frequency domain IVOCT system (CorVue,
Volcano Corporation, San Diego, California) while
the phantom vessel was ﬂushed with saline. The
IVOCT catheter was pulled back at a slow speed of
1.5 mm/s over a 15-mm length of vessel recording at
a rate of 30 frames/s. After stent deployment and
IVOCT imaging, micro-CT images of the phantom
vessel at resolution of 6 mm were recorded as a gold
image standard. Each recorded IVOCT image was
registered to a sequence of 8 micro-CT images due
to the spiral pattern associated with a pullback and
relatively larger longitudinal spacing between
IVOCT images. Figure 1 illustrates 2 successive
IVOCT images (Figures 1C and 1D) along with the
corresponding coregistered micro-CT images
(Figures 1E and 1F). The change in appearance of
groups of struts (indicated with green and yellow
ovals) can be observed in successive IVOCT and
micro-CT images. From the micro-CT image
sequence (Figures 1E and 1F), adjacent struts are
observed to merge (separate) at the arterial side of
the stent and form a micro-sized gap at the vessel
wall, with a different appearance at every gap. Flare
spots in the IVOCT images are only generated when
gaps appear in the micro-CT images on the arterial
side.
The micro-CT dataset was used to create a
3-dimensional representation of the entire stent
demonstrating that micro-crazes are formed on the
arterial side of the stent and therefore result in micro-
gaps at the vessel wall. There were 2 types of crazing,
which correspond to locations where 2 or 3 struts
merge (separate). During a pullback, the IVOCT beam
propagates through the vessel lumen, where portions
of light reﬂect from and transmit across the strut
edge. Light reﬂected from the strut edge forms an
outline of the outer surface of the strut in IVOCT
images. When the IVOCT beam enters a gap region
with micro-crazes, reﬂections at the gap boundary
occur before light returns to the catheter. The re-
ﬂections at gap boundaries produce ﬂare spots of
higher intensity inside struts in IVOCT images
(Figure 1G). Because each crazing site is different at
every hinge point, as demonstrated by the micro-CT
images (Figures 1E and 1F), the pattern of light
reﬂections is expected to vary, which is consistent
with the observation that no two ﬂare spots appear
identical in recorded IVOCT images.
In conclusion, we have completed imaging exper-
iments of an Absorb stent deployed in a phantom
vessel to investigate the origin of ﬂare spots observed
in IVOCT images of bioabsorbable stents. Flare spots
observed in IVOCT images correspond to gaps
observed in micro-CT images formed by micro-crazes
FIGURE 1 Flare Spots Observed in IVOCT Images of Absorb Stent
(A,B) Stent deployed in a patient coronary artery (arrows); (C,D) phantom vessel with successive intravascular optical coherence tomography
(IVOCT) images at 100-mm intervals; and (E,F) corresponding micro-CT images at 50-mm intervals. Adjacent struts (green and yellow ovals)
merge at the luminal side of the stents and form a gap at the vessel wall. (G) Reﬂections at gap boundaries result in ﬂare spots.
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1175on the arterial side of the stent. The appearance of
ﬂare spots in IVOCT images is consistent with light
reﬂecting from surfaces formed at these gap bound-
aries before returning to the catheter.Sahar Elahi, PhD
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2012;76:342–50.Cardiac Steatosis and Left Ventricular
Dysfunction in HIV-Infected Patients Treated
With Highly Active Antiretroviral TherapyHeart disease is a major contributor to morbidity and
mortality in persons infected with human immuno-
deﬁciency virus (HIV), and both HIV and highly active
antiretroviral therapy (HAART) may be associated
with abnormalities in cardiac function and meta-
bolism (1). Ectopic fat deposition in cardiomyocytes
constitutes one possible mechanism, especially
considering the inﬂuence of HIV itself and HAART
on the human metabolic milieu. To test this
hypothesis, we studied 27 HIV-seropositive (þ) cases
on stable HAART ($3 years) and 22 HIV-negative
control subjects; neither group had history of
personal or family history of cardiovascular disease.
Myocardial triglyceride content was measured by
magnetic resonance spectroscopy (3T MAGNETOM
Verio, Siemens, Germany) (2) and revealed a 3-fold
elevation in cases compared with control subjects
(Figure 1A). To assess left ventricular (LV) function,
magnetic resonance tissue tagging was performed
on a mid-ventricular short-axis image (3). Both peak
